Does Rallies show 13F holders for BEAT?

Yes. Rallies tracks hedge fund and 13F ownership data for BEAT, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BEAT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BEAT. It does not provide personalized investment advice.

BEAT (Heartbeam, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Heartbeam, Inc. Common Stock (BEAT) is a publicly traded Healthcare sector company. As of May 21, 2026, BEAT trades at $0.92 with a market cap of $53.25M and a P/E ratio of -1.51. BEAT moved +1.75% today. Year to date, BEAT is -66.51%; over the trailing twelve months it is -44.72%. Its 52-week range spans $0.54 to $4.00. Analyst consensus is strong buy with an average price target of $4.50. Rallies surfaces BEAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BEAT stock?

Hedge funds tracked by Rallies that own BEAT include Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Heartbeam, Inc. Common Stock.

BEAT Key Metrics

Key financial metrics for BEAT
Metric	Value
Price	$0.92
Market Cap	$53.25M
P/E Ratio	-1.51
EPS	$-0.62
Dividend Yield	0.00%
52-Week High	$4.00
52-Week Low	$0.54
Volume	4.48K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-21.02M
Gross Margin	0.00%

Top Hedge Funds Holding BEAT

Two Sigma holds 23.92K shares of BEAT, changed +0.00% as of Sep 30, 2024.

Latest BEAT News

HeartBeam Advances U.S. Commercial Launch, Raises $11.5M, Cuts Q1 Loss to $4.7M — May 14, 2026
HeartBeam to deploy leadless AI ECG platform in Atelier Health practices — May 7, 2026
HeartBeam Launches Next-Gen ECG System to Address 919,000 Annual U.S. Cardiac Deaths — May 6, 2026
HeartBeam Partners with Mount Sinai to Validate AI-Based 12-Lead ECG Algorithms — Apr 24, 2026
HeartBeam Raises $10M from 12.5M-Share Offering to Fuel ECG Technology Commercialization — Apr 17, 2026

Recent BEAT Insider Trades

Ferrari Richard bought 57.50K (~$46.00K) on Apr 16, 2026.
Cruickshank Tim bought 31.25K (~$25.00K) on Apr 16, 2026.
Elfrink Willem bought 187.50K (~$150.00K) on Apr 16, 2026.

BEAT Analyst Consensus

6 analysts cover BEAT: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.50.

Common questions about BEAT

Who owns BEAT stock?: Hedge funds tracked by Rallies that own BEAT include Two Sigma. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Heartbeam, Inc. Common Stock.
Does Rallies show 13F holders for BEAT?: Yes. Rallies tracks hedge fund and 13F ownership data for BEAT, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BEAT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BEAT. It does not provide personalized investment advice.